Annexon (ANNX) traded up 7.45 % during a 24 hours period ending at 06:46 AM Central Europe on Thursday 29th. One Annexon stock can currently be bought for about USD 4.04 on popular exchanges. Current supply of Annexon stocks is 187.6 mn. Annexon has a current market capitalization of USD 717.6 mn and approximately USD 16.2 mn worth of Annexon was traded on exchanges in the last 24 hours. Since last month end, Annexon has traded -2.18 % down. Simple moving average of last 200 days is at USD 5.24. The highest price of past 52 weeks was recorded at USD 7.18 on 01/23/2026. 52 weeks low was at USD 2.54 on 11/13/2025.
Here is how related stocks have performed in the past 24 hours:
Crossamerica (CAPL) traded up 1.34 % and now trades at USD 22.72. Current market capitalisation for Crossamerica is USD 855.8 mn. Crossamerica has a current price to earnings ratio of 16.5.
Daily Journal (DJCO) traded up 0.28 % and now trades at USD 612.62. Daily Journal has a market capitalisation of USD 841.8 mn.
P3 Health (PIII) traded up 5.77 % and now trades at USD 4.03. P3 Health has a market capitalisation of USD 857.9 mn.
Liberty Capital (GLIBA) traded down -0.9 % and now trades at USD 21. Liberty Capital has a market capitalisation of USD 853 mn.
Alumis (ALMS) traded up 7.38 % and now trades at USD 7.13. Alumis has a market capitalisation of USD 859.5 mn.
About Annexon
Annexon Inc., operating under the name Annexon Biosciences, is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company specializes in developing novel therapies for auto-immune and neurodegenerative diseases affecting body, eyes, and brain. Annexon Biosciences provides health care services for patients residing in the state of California. You can find more information about the company and its activities on their website, www.annexonbio.com , and they are listed on the Nasdaq stock exchange.